Fact based stock research
AmerisourceBergen (NYSE:ABC)


AmerisourceBergen stock research in summary

amerisourcebergen.com


AmerisourceBergen shares have a SELL rating. They show above average growth and are good value, but are riskily financed. We recommend selling AmerisourceBergen shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Distributors
Index S&P 500, D.J. US Health Care
Size class XX-Large

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()




Research History: AmerisourceBergen

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
44
71
38
52
STOCK GROWTH RANKS
44
40
56
56
STOCK SAFETY RANKS
7
15
32
12
COMBINED STOCK RANKS
11
35
16
24

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is AmerisourceBergen in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of AmerisourceBergen; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
74
57
48
48
PROFIT GROWTH
81
81
81
42
STOCK RETURNS
43
11
61
62
CONSOLIDATED RANK: GROWTH
44
40
56
56

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of AmerisourceBergen.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
27
32
48
41
REFINANCING
2
5
5
3
LIQUIDITY
20
42
38
38
CONSOLIDATED RANK: SAFETY
7
15
32
12

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of AmerisourceBergen and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for AmerisourceBergen from March 22, 2018.